abstract |
Novel peptide analogues which exhibit inhibitory activity against aspartic proteinases of the general formula I:, a novel species of actinomycetous microorganism which produces said novel peptide analogues, a process for producing said novel analogues by culturing said species and a pharmaceutical composition containing said analogues. |